                               SEQUENCE LISTING

<110> GENUITY SCIENCE, INC.
 
<120> METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF
      COVID-19

<130> HCI-00325

<140> PCT/US2022/028331
<141> 2022-05-09

<150> 63/186,560
<151> 2021-05-10

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
ggactcagag gattgctgca tttag                                             25


<210> 2
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
cttcgaagta gctgagtcat gctgg                                             25


<210> 3
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
ggtgaaggtc ggagtcaacg ga                                                22


<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
gagggatctc gctcctggaa ga                                                22


